Clinical Trial Update: APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML [Phase 1]

View source ↗

Summary

APVO436 is being studied in a Phase 1b/2 trial for newly diagnosed acute myeloid leukemia, with recruitment ongoing for the Phase 1 portion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• APVO436 (APVO436)

Snippet

Sponsor: Aptevo Therapeutics | Conditions: Acute Myeloid Leukemia (AML) | Phase 1 | Status: RECRUITING